MANUFACTURERS LIFE INSURANCE COMPANY, THE - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 108 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$84,922
-19.7%
15,5820.0%0.00%
Q2 2023$105,802
+31.1%
15,582
-3.3%
0.00%
Q1 2023$80,731
+2.7%
16,1140.0%0.00%
Q4 2022$78,636
-63.0%
16,114
+9.3%
0.00%
Q3 2022$212,594
-6.8%
14,743
-2.2%
0.00%
Q2 2022$228,085
+25.4%
15,075
-1.6%
0.00%
Q1 2022$181,942
-41.7%
15,315
-20.3%
0.00%
Q4 2021$312,000
-42.0%
19,220
+1.9%
0.00%
Q3 2021$538,000
-21.2%
18,856
-6.6%
0.00%
-100.0%
Q2 2021$683,000
+27.0%
20,197
+13.6%
0.00%
Q1 2021$538,000
-41.5%
17,785
-4.2%
0.00%
-100.0%
Q4 2020$920,000
+34.3%
18,573
+4.1%
0.00%0.0%
Q3 2020$685,000
-17.3%
17,840
-1.6%
0.00%0.0%
Q2 2020$828,000
+106.5%
18,127
+18.1%
0.00%
Q1 2020$401,000
-0.2%
15,353
+19.3%
0.00%
Q4 2019$402,000
+15.9%
12,868
-4.4%
0.00%
Q3 2019$347,000
+16.1%
13,467
+2.9%
0.00%
Q2 2019$299,00013,0890.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders